✨ Your Portfolio is fetched and updated from zerodha.
Market Cap
₹850 Cr.
P/E
71.35
About
Shivalik Rasayan Ltd. (SRL), established in 1981, is a manufacturer of organophosphorous based insecticides and chemicals. SRL today produces international quality Malathion Technical and Dimethoate T… Read more
Shivalik Rasayan Ltd. (SRL), established in 1981, is a manufacturer of organophosphorous based… Read more
Low
498
52W Range
High
777
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Custom financial statement
Edit rows
Forensics

5 Yes

Positive for this company

3 Neutral

Neutral for this company

8 No

Negative for this company

1 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Operating Profit Break-Up

Asset Break-Up

Operational Metrics

    Select a Metric
    • Capacity Utilization - Dimethoate (%)
    • Realization/Tonne - Dimethoate (Rs/MT)
    • Realization/Tonne - Sodium hydrosulfide (Rs/MT)
    Peer Comparison
    FAQs on Shivalik Rasayan Ltd. Business

    Established in 1981, Shivalik Rasayan Ltd. (SRL) is a leading manufacturer of international quality Malathion Technical and Dimethoate Technical, well established in Indian and foreign markets.

    Shivalik Rasayan major competitors are Albert David, Ind-Swift Lab., Kwality Pharma, Wanbury, Sakar Healthcare, Prevest Denpro, Gennex Lab.
    Market Cap of Shivalik Rasayan is ₹850 Crs.
    While the median market cap of its peers are ₹800 Crs.

    Shivalik Rasayan seems to be less financially stable compared to its competitors.
    Altman Z score of Shivalik Rasayan is 5637114.74 and is ranked 5 out of its 8 competitors.

    Company Filing
    2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Jun Sep Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Jun Sep Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Jun Sep Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary Jun Sep Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Discussions & Analysis